Bellwether Advisors’s MacroGenics MGNX Stock Holding History

Bellwether Advisors’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-192	Closed	-$1K	–	505
2022 Q1	$1K	Hold	192	–	–	﹤0.01%	511
2021 Q4	$3K	Buy	192 +52	+37%	+$979	﹤0.01%	459
2021 Q3	$2K	Buy	+140	New	+$3.37K	﹤0.01%	477

Other funds holding MGNX

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Bellwether Advisors's MGNX Position: Q2 2022 in Review

Bellwether Advisors sold out of MacroGenics (MGNX) in Q2 2022, closing a stake of 192 shares — an estimated $1K sold.

Bellwether Advisors first reported a position in MGNX in Q3 2021 and held it in 3 quarters. The position peaked at $3K in Q4 2021. 133 funds tracked by Wall St. Rank hold MGNX as of Q2 2022.

Bellwether Advisors reported no remaining MacroGenics position as of Q2 2022 after selling out during the quarter.
Bellwether Advisors sold 192 MacroGenics shares in Q2 2022, an estimated $1K.
Bellwether Advisors first reported a position in MacroGenics in Q3 2021 and held it in 3 quarters.
Bellwether Advisors's MacroGenics position peaked at $3K in Q4 2021.
133 funds tracked by Wall St. Rank held MacroGenics as of Q2 2022.

Based on Bellwether Advisors's 13F filing for Q2 2022, filed 5 Aug 2022.